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Introduction
The first step of drug discovery is commonly referred to as
lead identification. Screening techniques such as enzyme-linked
immunosorbent assays (ELISA),[1] surface plasmon resonance
(SPR, also known under the trade name Biacore),[2] isothermal
titration calorimetry (ITC),[3] fluorescence anisotropy,[4] and an
ever-expanding range of nuclear magnetic resonance (NMR)
techniques[5] allow one to recognize ligands or fragments
thereof in extensive libraries of chemical compounds. The
binding of a ligand to a target protein:
Pþ L Ð PL ð1Þ
can be described by a dissociation constant KD that gives
a measure of the affinity:[6]
KD ¼
P½  L½ 
PL½  ¼
koff
kon
ð2Þ
in which [L], [P] , and [PL] are the respective concentrations of
the free ligand, the free protein, and the protein–ligand com-
plex, and kon and koff are second- and first-order rate constants
of the association and dissociation reactions. In NMR, a first-
order exchange rate is defined as kex= (kon[P]+koff). If the bind-
ing site of the protein is saturated by excess ligand, that is, if
[PL]! [L] , one has kexkoff. Typically, good drugs have small
dissociation constants with KD<1 mm.
Because one can choose from a wide range of observable
parameters, NMR spectroscopy offers several methods to study
interactions between small ligand molecules and macromolec-
Transverse and longitudinal relaxation times (T11 and T1) have
been widely exploited in NMR to probe the binding of ligands
and putative drugs to target proteins. We have shown recently
that long-lived states (LLS) can be more sensitive to ligand
binding. LLS can be excited if the ligand comprises at least
two coupled spins. Herein we broaden the scope of ligand
screening by LLS to arbitrary ligands by covalent attachment
of a functional group, which comprises a pair of coupled pro-
tons that are isolated from neighboring magnetic nuclei. The
resulting functionalized ligands have longitudinal relaxation
times T1(
1H) that are sufficiently long to allow the powerful
combination of LLS with dissolution dynamic nuclear polariza-
tion (D-DNP). Hyperpolarized weak “spy ligands” can be dis-
placed by high-affinity competitors. Hyperpolarized LLS allow
one to decrease both protein and ligand concentrations to mi-
cromolar levels and to significantly increase sample through-
put.
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ular targets. It is possible to extract dissociation constants[7]
and to obtain structural information about the protein and its
complex.[8] Provided the exchange between the free and
bound forms of the ligand is faster than the difference of their
resonance frequencies,[5a,9] i.e. , when kexkoff@ (p/
ﬃﬃﬃ
2
p
)Dn,
where Dn is the chemical shift difference (in Hz) of the signals
in the bound and free states, any observable quantity xobs, be
it a frequency or a relaxation rate, is determined by a weighted
average of the free and bound forms:[10]
xobs ¼ Xboundxbound þ X freexfree ð3Þ
for which Xbound and Xfree are the mole fractions of the bound
and free ligands. The larger the contrast,
Cx ¼
xfree  xobs
xfree þ xobs








ð4Þ
the more sensitive the frequency or relaxation rate is to
ligand–protein binding. This expression is more general than
the definition of contrast that we proposed in our first report
on the subject.[11]
Several NMR methods based on such a contrast are exten-
sively used nowadays to determine dissociation constants of
ligand–protein interactions. The quantity xobs can be deter-
mined by the chemical shifts of one or more selected nuclei of
either target proteins[12] or ligands,[13] the translational or rota-
tional diffusion constant of the ligand,[14] the auto-relaxation
rates T1, T2 and T11, the rate of magnetization transfer by cross-
relaxation (Overhauser effect) between protons belonging to
the ligand,[15] the saturation transfer from proteins to ligands
determined by difference spectroscopy,[16] or “water-LOGSY”
that exploits differences of the rate of transfer of magnetiza-
tion from bulk water to free or bound ligands by cross-relaxa-
tion.[17] Several of these methods rely on differences in rota-
tional correlation times between the free ligand and the pro-
tein–ligand complex.[18]
We recently demonstrated that so-called long-lived states
(LLS), also known as singlet states (SS) in isolated two-spin sys-
tems, can be used very effectively to investigate protein–ligand
interactions.[11] Indeed, the protracted lifetimes TLLS of these nu-
clear spin states are exquisitely sensitive to binding to a protein,
giving a dramatic contrast between the lifetimes TLLS of the
bound and free forms. Similar rules apply to the lifetimes TLLC of
so-called long-lived coherences (LLC).[19] A drawback of both
LLS and LLC methods is that the ligands should contain reason-
ably isolated two-spin systems. We show in this work that it is
possible to overcome this limitation by covalent attachment of
a “spin-pair label” carrying an isolated two-spin system.
The requirement of rapid exchange underlying Equation (3)
implies that “direct” NMR binding experiments cannot be used
for ligands with strong affinities (KD<100 mm), although good
drugs typically have much smaller dissociation constants KD<
1 mm. Fortunately, so-called “competition binding” experiments
can be used to determine small dissociation constants KD of
competitors that can displace weak “spy ligands” from the
binding sites of target proteins. We show here how a weak
ligand with a spin-pair label capable of sustaining an LLS or
LLC can be used as a “spy ligand” in competition experiments.
If a competitor partly displaces the spy ligand, the lifetimes TLLS
and TLLC of the spy ligand can be dramatically extended. A set
of 1D experiments allows one to screen and rank extensive li-
braries of compounds. Such “indirect” competition binding ex-
periments[20] open the way to the identification of high-affinity
ligands with KD<1 mm, typical of effective drugs. Remarkably,
competition binding experiments can also be used to deter-
mine poor binding constants KD>10 mm that are typical of
weakly binding “lead compounds” that tend to be difficult to
identify in the early stages of drug discovery.[21]
It is clearly desirable to use low concentrations of both pro-
teins and ligands, not only to save expensive materials, but
also to avoid protein aggregation and problems with mixtures
(“cocktails”) in the manner of combinatorial chemistry. The
quest for low ligand concentrations is generally limited by
poor sensitivity of NMR. At concentrations [L]<100 mm, NMR
spectra with sufficient signal-to-noise ratios require extensive
signal averaging. Hyperpolarization of nuclear spins by dissolu-
tion dynamic nuclear polarization (D-DNP)[22] can overcome
this problem. By microwave irradiation of samples at tempera-
tures close to T=1.2 K, the polarization of electron spins can
be transferred to protons or other nuclei, followed by rapid
dissolution of the hyperpolarized samples and their transfer to
a high-resolution NMR spectrometer for detection. The tech-
nique has not been very popular for 1H and 19F nuclei so far,
because rapid T1 relaxation tends to cause loss of polarization
during the transfer from the polarizer to the spectrometer. En-
hancements eDNP up to five orders of magnitude can be ob-
tained for nuclei with low gyromagnetic ratios, while enhance-
ments 100<eDNP<1000 can be achieved for
1H or 19F nuclei.[23]
Spin-pair-labeled molecules containing isolated spins designed
for LLS and LLC experiments also feature fairly long T1 values
which also makes them suitable for dissolution DNP.
Long-lived states experiments
Long-lived states (LLS), first described by Levitt and co-work-
ers,[24] have the unique property that their populations relax
with time constants that can be much longer than longitudinal
relaxation time constants (TLLS@T1). For pairs of protons, TLLS/T1
ratios as large as 60 have been observed in RCH=CHR’ sys-
tems. To perform an LLS experiment, one has to: 1) Start with
a system comprising two nonequivalent spins and convert
their populations into a density operator corresponding to
a singlet–triplet imbalance (Figure 1a, 1–2);[24a,25] 2) Sustain the
LLS by suppressing the effects of the chemical shift difference
(Figure 1a, 2–3), usually by applying a resonant radiofrequency
(rf) field during a sustaining time tm, with the carrier (nrf)
placed halfway between the chemical shifts of the two spin-
s;[24a,d,26] LLS are efficiently sustained by an rf field that is at
least five times larger than the chemical shift difference be-
tween the two spins. 3) After turning off the resonant rf field,
a suitable pulse sequence can convert the singlet–triplet im-
balance back to observable magnetization (Figure 1a, 3–4).
The lifetime of the LLS can be determined by fitting the signal
 2014 The Authors. Published by Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim ChemMedChem 2014, 9, 2509 – 2515 2510
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intensities recorded as a function of tm to the exponential
function exp(tm/TLLS).
On the other hand, long-lived coherences (LLC)[19] have the
property that they relax with time constants that can be much
longer than transverse relaxation time constants (TLLC@T2). The
principles of LLC spectroscopy are briefly reviewed in the Sup-
porting Information.
Results and Discussion
Enhanced contrast of LLS
In direct titration experiments, i.e. , in the absence of competi-
tors, the relaxation rate of a (weak or intermediate) spy ligand
is measured by titration as a function of the protein-to-ligand
ratio. An LLS associated with a ligand L bound to a target pro-
tein P will relax faster, that is, TLLS
bound!TLLS
free. The relaxation
properties of free and bound ligands contribute to increase
the contrast C(TLLS) of the method. According to Equation (4),
one may define the contrast as:
C TLLSð Þ ¼
RfreeLLS  RobsLLS
RfreeLLS þ RobsLLS








¼ T
free
LLS  TobsLLS
T freeLLS þ TobsLLS








ð5Þ
where RLLS
obs and TLLS
obs are the averaged parameters observed
for the rapid equilibrium between free and bound forms of the
ligand in the sense of Equation (3), while RLLS
free and TLLS
free refer
to the free ligand in the absence of protein. By analogy, an ex-
pression for the contrast C(TLLC) of long-lived coherences can
be derived from Equation (5) by replacing LLS with LLC.
To demonstrate the enhancement of the contrast C(TLLS)
with respect to the contrast C(T1) and C(T11), binding experi-
ments were carried out for a 1 mm solution of the tripeptide
ligand glycine-glycine-arginine (GGR) in the presence of its pro-
tein target trypsin in the range 0.5< [P]<50 mm, using various
methods (TLLS, nonselective T1 and nonselective T11). Figure 2
shows that the LLS method can work with a protein–ligand
ratio that is ~25-fold lower than required for the well-known
nonselective T11 method, whereas the nonselective T1 contrast
remains below C(T1)<10% even at the highest protein concen-
tration [P]=50 mm.
Spin-pair labeling
A drawback of screening by LLS or LLC is that the ligands
must carry a pair of nonequivalent spins 1=2. We therefore de-
veloped a synthetic labeling strategy comprising two steps:
1) the identification of a “spy ligand” that binds weakly to the
target protein, and 2) the functionalization (see Supporting In-
formation) of this ligand by attaching a “spin-pair label” that
can carry LLS or LLC. By way of illustration, 3-bromothiophene-
2-carboxylic acid (“BT”), which is known to have long lifetimes
TLLS and TLLC,
[27] was covalently attached to the tripeptide GGR,
a weak binder for trypsin. The resulting spin-pair-labeled tri-
peptide is henceforth called BT-GGR.
Despite some steric effects and long-range dipolar relaxation
mechanisms in the spin-pair-labeled tripeptide BT-GGR, the
two aromatic protons of the bromothiophene group retain
a remarkably long lifetime TLLS
free(BT)=11.70.7 s. In this par-
ticular peptide, the diastereotopic pairs of a-protons on the
two glycine residues of BT-G1G2R can also be used to excite
LLS and have lifetimes TLLS
free(G1)=10.40.5 s and TLLSfree(G2)=
9.30.5 s (see Figure 3b).
The observed averaged relaxation rate of LLS in the pres-
ence of a protein can be derived from Equation (3), using the
definition of KD of Equation (2) and assuming saturation, i.e. ,
[L]0@ [PL], so that [L]0[PL] [L]0 :
RobsLLS ¼
P½ 0
KD þ L½ 0 R
bound
LLS  RfreeLLS
 þ RfreeLLS ð6Þ
If one measures RLLS
obs as a function of the concentration [L]0
of a ligand while [P]0 is kept constant, it is possible to deter-
mine KD by fitting to Equation (6). The spin-pair-labeled spy
ligand L=BT-GGR was added to a solution of [P]0=25 mm tryp-
sin over a range 0.5< [L]0<40 mm. At each concentration [L]0,
Figure 2. Contrast of life-times TLLS, T1, and T11 of ligands binding to proteins.
Experimental contrast for TLLS (*), non-selective T11 (&), and non-selective
T1 (N) methods for the diastereotopic pair of protons on the middle glycine
residue of the tripeptide GGR in a solution with a fixed concentration
[L]=1 mm and a variable trypsin concentration 0.5 mm< [P]0<50 mm in D2O
at 8 8C at 11.7 T (500 MHz for protons).
Figure 1. Experiments for long-lived states (LLS) and long-lived coherences
(LLC). a) Pulse sequence used to excite, sustain, and observe LLS.[25] An rf
field is applied between time points 2 and 3 with the carrier halfway be-
tween the chemical shifts of the two spins in order to make them effectively
equivalent. The conversion is most efficient if t1=1/4 JIS and t2=1/2DnIS.
b) Pulse sequence designed to excite, sustain, and detect LLC. Typically,
t1=1/2DnIS to achieve an efficient conversion of Iy+Sy into IxSx, and
d1=5T1. A variant for single-scan LLC spectroscopy is described in the
Supporting Information.
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the observed relaxation times TLLS
obs=1/RLLS
obs of three different
pairs of protons (belonging to the bromothiophene group and
to the middle and the terminal glycines) were measured using
the pulse sequence of Figure 1. Figure 3a shows how the titra-
tion curves can be fitted to Equation (6). As expected, nearly
the same dissociation constants were obtained for the three
proton pairs that can sustain LLS in BT-GGR: KD(BT)=0.18
0.03 mm, KD(G1)=0.240.01 mm, KD(G2)=0.210.02 mm. The
LLS fitted lifetime of G2 (i.e. , the glycine closest to the arginine)
in the bound form (TLLS
bound(G2)=161 ms) is shorter than for
the two other LLS sites (TLLS
bound(BT)=9020 ms, TLLSbound(G1)=
11040 ms). This shorter TLLSbound is believed to be due to the
fact that the arginine, and thus also the glycine G2, enter more
deeply into the active site of trypsin.
Competition binding experiments
Once a weak ligand has been identified and characterized by
titration, it can be used as a “spy ligand” in competition experi-
ments.[20] When stronger ligands are added, the lifetime TLLS
obs
of the spy ligand give information about the dissociation con-
stant KD
strong of the competitor. Note that the competitor need
not contain any spin pairs that can sustain an LLS or LLC.
Moreover, as the changes in TLLS
obs need only be observed for
the weak ligand, there are no requirements for the stronger li-
gands to fulfill the fast-exchange condition. This implies that
the accessible range of dissociation constants KD
strong of the
competitor can lie in a range 0.1 nm<KD
strong<100 nm. When
KD
strong<0.1 nm, one can detect a large effect on the lifetime
TLLS
obs of the weak spy ligand, but it is not possible to rank the
ligands according to their affinities. As the strong competitors
themselves need not be observed directly, their concentration
can also be lowered, typically to the same level as the concen-
tration of the protein, that is, to [L]0 [P]0, which may typically
be in the single-digit micromolar range.
When a stronger competitor blocks the active site of the
protein, the weak spy ligand will no longer have free access to
its target. The concentration [P]free of the protein that remains
free to bind the weak ligand can be derived from the defini-
tion of the dissociation constant KD
strong of the competitor:
P½ free¼ P½ 0
b ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃb2  4 P½ 0 Lstrong½ 0
p
2
ð7Þ
where b= ([P]0+ [L
strong]0+KD
strong) and [Lstrong]0 is the total con-
centration of the competitor. As the amount of free available
protein decreases, the effects of the protein on the lifetime
TLLS
obs of the weak spy ligand will be less pronounced. Here,
the approximation that the binding sites are saturated by li-
gands cannot be made, since [Lstrong]0 [P]0. To describe the re-
laxation rate RLLS
obs of the weak spy ligand in competition ex-
periments, [P]0 in Equation (6) must be replaced by [P]free of
Equation (7).
Once the dissociation constant KD
weak of the weak spy ligand
and its LLS lifetime in the bound form TLLS
bound are known, it is
possible to optimize [Lstrong]0 and [P]0 to rank strong competi-
tors according to their binding strengths. Figure 4 shows the
calculated TLLS
obs(BT) of the bromothiophene protons in BT-GGR
if [P]0=25 mm and [L
strong]0=50 mm as function of KD
strong. Under
these conditions, TLLS
obs changes dramatically between KD
strong=
100 mm and KD
strong=1 mm.
A library of competing ligands can thus be ranked according
to their affinities by observing the LLS signal of the weak spy
ligand. Under the conditions shown in Figure 4, one can easily
rank competing ligands with great accuracy provided 1 mm<
KD
strong<100 mm. Note that the LLS sequence of Figure 1 can
be used with a single sustaining delay tm. This strategy is com-
Figure 3. LLS titration experiments. a) Observed LLS lifetimes of the three
proton pairs on the spin-pair-labeled tripeptide BT-GGR as a function of the
ligand concentration, in the presence of 25 mm trypsin in D2O at 25 8C and
11.7 T (500 MHz for protons). b) Pairs of protons capable of sustaining LLS in
BT-GGR: on bromothiophene BT (orange), on the N-terminal glycine G1
(blue) and on central glycine G2 (green) which is close to the arginine resi-
due that binds to the protein.
Figure 4. Influence of a competitor on the LLS lifetime of a weak ligand. The
LLS lifetimes TLLS
obs of the pair of aromatic protons of the bromothiophene
spin-pair label as a function of the dissociation constant of a competing
stronger ligand, calculated using Equations (6) and (7). The parameters of
the weak ligand BT-GGR were obtained from the fit of the data in Figure 3:
KD=0.2 mm, TLLS
bound=0.1 s, TLLS
free=11 s, [L]0=0.5 mm, [P]0=25 mm, and
[Ls]0=50 mm. The three points correspond to TLLS
obs in the presence of myri-
cetin (KD
strong=3 mm, *), apigenin (KD
strong=39 mm, &) and in the absence of
any competitor (N) calculated for these conditions.
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patible with dissolution DNP, as discussed below. As TLLS
obs of
the weak spy ligand is longer in the presence of a stronger
competitor, the LLS signal intensity of the spy ligand after
a suitably chosen delay tm will be higher. LLS spectra with tm=
3 s were recorded with 0.5 mm BT-GGR, in the presence of
[P]0=25 mm trypsin with four different competitors, all with
[Lstrong]0=50 mm : myricetin (KD
strong=3 mm), morin (KD
strong=
30 mm), apigenin (KD
strong=39 mm)[28] and benzamidine (KD
strong=
39 mm).[29] Figure 5a shows three of these five LLS spectra, ob-
tained either without competitor, with apigenin, or with myri-
cetin. Figure 5b shows the signal intensities of the weak spy
ligand BT-GGR in the presence of one of the four competing li-
gands. The same kind of information can be derived from the
lifetimes of long-lived coherences (Figure 5c,d).
Hyperpolarization by dissolution DNP
Ligands with covalently attached spin-pair labels such as BT-
GGR contain spins with long T1 values and are therefore suita-
ble for hyperpolarization by dissolution DNP. Provided T1(
1H)>
1 s, a sufficient fraction of the hyperpolarized magnetization
can be preserved during transfer from the DNP polarizer to the
NMR spectrometer.
In a glass-forming solvent mixture H2O/D2O/[D6]DMSO
(v/v/v=5:35:60), 10 mm BT-GGR was dissolved with 25 mm
4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl (TEMPOL). Five
frozen beads (50 mL) of this solution were loaded together
with five frozen beads (50 mL) of 3m ascorbate[30] into a home-
built DNP polarizer[31] operating at B0=6.7 T and T=1.2 K. The
sample was irradiated with microwaves at a frequency fmW=
188.3 GHz and power PmW=100 mW. Unlike trityl radicals, the
nitroxyl radical TEMPO is an efficient polarizing agent for 1H
spins, because it has a broad ESR line DwESR>w0(
1H).[32] At B0=
6.7 T, a proton polarization up to P(1H)=90% can be obtai-
ned,[31b] while P(1H) is only ~40% in polarizers operating at
B0=3.35 T. After ~15 min of microwave irradiation, a steady-
state proton polarization P(1H) is reached. The DNP sample can
be rapidly dissolved in 0.7 s with 5 mL of hot D2O (P=1 MPa,
T=400 K) and transferred to a 11.7 T NMR spectrometer in
4.5 s through a “magnetic tunnel” so that B0>0.8 T during
transfer, which is particularly important to preserve the polari-
zation of 1H and 19F nuclei.[33] A fraction (400 mL) of the hyper-
polarized solution is then injected in ~2 s into a 5 mm NMR
tube containing 250 mL D2O and, depending on the conditions,
3.65 mm trypsin and 3.65 mm of a competitor such as myricetin.
After injection, the final solution has a concentration of 1.4 mm
protein, 1.4 mm competitor, and 120 mm hyperpolarized spy
ligand BT-GGR. After a 3 s interval to allow proper mixing, a ref-
erence free induction decay is observed in 0.5 s after exciting
transverse magnetization with a single 58 pulse to control the
quality of the hyperpolarized sample and to normalize the
signal intensity of the spy ligand to its known concentration.
Figure 5. LLS and LLC competition binding experiments. a) Signals of one of the two aromatic protons of bromothiophene of 0.5 mm of the weak spy ligand
BT-GGR in the presence of 25 mm trypsin, using the LLS sequence of Figure 1 with a sustaining time tm=3 s in D2O at 25 8C and 11.7 T (500 MHz for protons)
1) in the absence of any competitor (orange), 2) in competition with 50 mm of the intermediate ligand apigenin (blue), and 3) in competition with 50 mm of
the stronger ligand myricetin (green). b) Peak intensities of one of the aromatic protons of BT-GGR under the same conditions as in panel a), without compet-
itor or in the presence of apigenin, benzamidine, morin, or myricetin. The better the binding, the smaller the dissociation constant, and the more intense the
LLS signal of the displaced spin-pair-labeled spy ligand BT-GGR. c) LLC spectra of the two aromatic protons of the bromothiophene group of BT-GGR acquired
with the “on-the-fly” sequence shown in Figure S2b of the Supporting Information, under the same conditions as in panel a). The stronger the binding of
competitors, the greater the displacement of the spy ligand BT-GGR, the narrower the peaks in its LLC spectra, and the more intense the signals. d) Line
widths of LLC peaks [DnLLC
obs=1/(pTLLC
obs)] .
 2014 The Authors. Published by Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim ChemMedChem 2014, 9, 2509 – 2515 2513
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This is immediately followed by an LLS sequence as described
in Figure 1 with a fixed sustaining time tm=3 s.
The DNP enhancements of the aromatic protons of the spin-
pair-labeled spy ligand BT-GGR were on the order of eDNP=
100–200, relative to Boltzmann equilibrium at 25 8C and 11.7 T
(500 MHz for protons). A significant fraction of the proton hy-
perpolarization was lost during the 10 s interval between dis-
solution and signal acquisition, but a faster sample injection
device[33] could decrease this interval to 1.2 s.
Figure 6 shows DNP-enhanced LLS spectra of 1) 120 mm of
the spin-pair-labeled spy ligand BT-GGR in the absence of pro-
tein, 2) the same upon addition of 1.4 mm trypsin, and 3) the
same with further addition of 1.4 mm myricetin as competitor.
A dramatic decrease of the LLS signal intensity stemming from
BT-GGR is observed upon adding trypsin. The contrast defined
in Equation (5) is C(TLLS)=75%. Addition of an equimolar
amount of the competitor myricetin leads to a partial displace-
ment of the spy ligand that can be readily detected by the re-
vival of its LLS signal. With only 120 mm of the spin-pair-labeled
spy ligand BT-GGR, the DNP-enhanced LLS spectrum of
Figure 6 recorded in a single scan after tm=3 s has a signal-to-
noise ratio (SNR) of 130. Under the same conditions, but with-
out DNP, an accumulation of 225 transients for ~1 h was nec-
essary to reach the same SNR. A DNP-enhanced LLS spectrum
of BT-GGR with a concentration as low as 10 mm could be re-
corded with an SNR of 16. Clearly, DNP allows one to decrease
the concentration of ligands, but the protein concentration
should not be further decreased. In fact, according to Equa-
tion (6), the contrast CLLS would decrease if the limit KD+ [L0]
KD were to be reached. Without DNP, using a 50-fold increase
in ligand concentration (Figure 5), 256 transients had to be ac-
cumulated in 100 min to obtain an SNR of 8. The experimental
conditions can be adapted depending on the primary objec-
tive: low concentrations of either protein or ligand, rapid
throughput, high sensitivity for the displacement by a competi-
tor or high SNR. In Figure 6, the conditions were optimized for
high SNR and high contrast upon addition of a competitor,
albeit at the expense of a slightly higher ligand concentration
and longer polarization buildup time. To attain faster through-
put, one could polarize at a higher temperature T=4.2 K and
B0=6.7 T, where proton polarization P(
1H)=25% can be
reached by DNP in ~2 min.[31b] The price to pay would be an
approximate threefold lower SNR. Similarly, at T=1.2 K and
B0=3.35 T, as in commercially available DNP polarizers, P(
1H)=
40% can be reached in ~6 min.[34]
Conclusions
The covalent attachment of “spin-pair labels” such as bromo-
thiophene (BT) permits one to broaden the scope of the LLS
and LLC screening methods to virtually any weak ligand in the
fast exchange regime. By way of example, bromothiophene
carboxylic acid was attached to the N terminus of a tripeptide,
but other “spin-pair labels” could be designed. Spy ligands
with higher sensitivity to binding could be engineered with
the following features: 1) spy ligands with enhanced TLLS
free,
2) LLS functionalizing groups closer to the binding site, 3) the
use of nearly equivalent spins.[35] Our labels are far less bulky
than chromophores used in fluorescence experiments, and
should not induce significant steric impediments to binding.
Relative to other NMR screening methods, LLS and LLC offer
much improved contrast. For the same ligand concentration
(i.e. , for the same experimental time), the protein concentra-
tions can be greatly decreased, giving access to poorly soluble
protein targets and decreasing the risk of aggregation. When
used in competition mode, both LLS and LLC methods allow
one to rank high-affinity ligands using simple 1D experiments.
Because there are few protons in the spin-pair label, they tend
to have long T1 relaxation times, so that drug screening experi-
ments using LLS or LLC can be, in principle, readily coupled to
D-DNP. Currently, access to this technology remains limited to
a few specialized groups, but a dedicated LLS-DNP screening
apparatus could be made commercially available in the near
future. As demonstrated below, this approach allows one to
decrease the concentrations of spy ligands, competitors and
target proteins. In our current setup, the time required for
transfer from the polarizer to the detection magnet is similar
to T1(
1H) of the spy ligand. An acceleration of the transfer
would benefit the remaining proton polarization and thus the
SNR. Such improvements would allow either a further decrease
in ligand concentration or an increase in sample throughput.
Experimental Section
Samples : BT-GGR (see Supporting Information for details
about the synthesis) was titrated over the range 0.5< [L]0<
40 mm into 25 mm type IX-S trypsin from porcine pancreas
(Sigma–Aldrich). As internal concentration standard, 5 mm tert-
butyl alcohol (>99.5%, Sigma–Aldrich) was added. Five solu-
tions containing 0.5 mm BT-GGR and 25 mm trypsin in D2O
were prepared for competition experiments: 1) without com-
petitor, 2) with 50 mm myricetin (>96%, Sigma–Aldrich),
3) with 50 mm morin hydrate (Sigma–Aldrich), 4) with 50 mm
apigenin (>97%, Sigma–Aldrich), and 5) with 50 mm benzami-
dine hydrochloride (>99%, Sigma–Aldrich).
Figure 6. DNP-enhanced LLS competition binding experiments. DNP-en-
hanced LLS spectra of the two aromatic protons of bromothiophene in BT-
GGR 120 mm after a sustaining time tm=3 s, 1) without protein (black), 2) in
the presence of 1.4 mm trypsin (orange), 3) with 1.4 mm trypsin and 1.4 mm
myricetin as competitor (green). All spectra were acquired in a single scan in
D2O, at 25 8C and 11.7 T (500 MHz for protons).
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Experimental procedures : During the titrations, 2 mL aliquots of
150 mm BT-GGR were added to 300 mL of the starting solution.
The lifetimes TLLS
obs were determined by single-exponential fit-
ting of signal intensities observed with the LLS sequence of
Figure 1, setting the sustaining field strength B1=5DnIS, and
using N=10 different delays tm=n1Dtm with Dtm=TLLS
expected/10
and n1=1, 3, 6, 10, 15, 21, 29, 37, 46, 56. All measurements were
performed at 258C on a 500 MHz (11.7 T) Avance Bruker spec-
trometer equipped with an inverse detection 5 mm CryoProbe.
Dissolution-DNP experiments : Solutions of 10 mm BT-GGR in
the glass-forming mixture H2O/D2O/[D6]DMSO (v/v/v=5:35:60)
were doped with 25 mm TEMPOL (Sigma–Aldrich). Five frozen
beads of 10 mL each of this mixture were inserted with five
frozen beads of 10 mL each containing 3m ascorbate in D2O to
scavenge the radicals after dissolution. DNP was performed at
1.2 K and 6.7 T in a home-built polarizer by applying CW micro-
wave irradiation at fmW=188.3 GHz and PmW=100 mW. The
beads were dissolved together in 0.7 s with 5 mL D2O, preheat-
ed at T=400 K at P=1.0 MPa, and transferred in 4.5 s by pres-
surizing with helium gas at 0.6 MPa to an 11.7 T Bruker magnet
via a 1.5 mm inner-diameter PTFE tube running through a mag-
netic tunnel of 5 m length. After injection in 2 s into NMR
tubes containing 250 mL of D2O to allow field-frequency lock-
ing before and during injection, plus 1) 250 mL of 3.65 mm tryp-
sin, or 2) 250 mL of 3.65 mm trypsin and 3.65 mm myricetin. A 58
detection pulse was applied to record a hyperpolarized 1H
signal for reference, followed by a single LLS sequence with
a sustaining delay tm=3 s.
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